510(k) K231133
K231133 is an FDA 510(k) premarket notification submitted by Neoscan Solution GmbH for the device "neo315". The FDA issued a decision of Substantially Equivalent on July 22, 2024. The device falls under product code LNH (System, Nuclear Magnetic Resonance Imaging), a Class II device regulated under 21 CFR 892.1000.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 22, 2024
- Date Received
- April 21, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Nuclear Magnetic Resonance Imaging
- Device Class
- Class II
- Regulation Number
- 892.1000
- Review Panel
- RA
- Submission Type